Skip to content

Depreciation at other companies

Danaher logo
DanaherDHR
Fortive logo
FortiveFTV
NeoGenomics logo
NeoGenomicsNEO
Sotera Health logo
Sotera HealthSHC
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's depreciation?
Mesa Laboratories (MLAB) reported depreciation of $1.27M in Q1 2026.
How has Mesa Laboratories's depreciation changed year-over-year?
Mesa Laboratories's depreciation decreased by 6.6% year-over-year, from $1.35M to $1.27M.
What is the long-term trend for Mesa Laboratories's depreciation?
Over 3 years (2022 to 2026), Mesa Laboratories's depreciation has grown at a 17.2% compound annual growth rate (CAGR), from $3.26M to $5.25M.